We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

128 hedge funds and large institutions have $160M invested in Arena Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 32

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

21% more call options, than puts

Call options by funds: $1.39M | Put options by funds: $1.15M

2% more funds holding

Funds holding: 125 → 128 (+3)

24% less capital invested

Capital invested by funds: $210M → $160M (-$50M)

Holders
128
Holders Change
+3
Holders Change %
+2.4%
% of All Funds
3.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
52
Reduced
32
Closed
14
Calls
$1.39M
Puts
$1.15M
Net Calls
+$245K
Net Calls Change
-$191K

Top Buyers

1
AC
Ascend Capital
California
+$2.83M
2
BFA
BlackRock Fund Advisors
California
+$1.88M
3
PAM
Panagora Asset Management
Massachusetts
+$1.21M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.12M
5
Morgan Stanley
Morgan Stanley
New York
+$973K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.8M
2
CCM
Camber Capital Management
Massachusetts
-$9.68M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.93M
4
GC
Globeflex Capital
California
-$1M
5
TC
TFS Capital
Pennsylvania
-$818K
Name Holding Trade Value Shares
Change 		Change in
Stake
WS
101
Wedbush Securities
California
$18K -$4.96K -320 -21%
LPL Financial
102
LPL Financial
California
$18K – – –
FCB
103
First Command Bank
Texas
$18K +$20.1K +1,300 New
FCFS
104
First Command Financial Services
Texas
$18K +$20.1K +1,300 New
Simplex Trading
105
Simplex Trading
Illinois
$15K -$17.1K -1,102 -51%
Two Sigma Investments
106
Two Sigma Investments
New York
$15K +$16.1K +1,041 New
JCM
107
Jacobi Capital Management
Pennsylvania
$14K -$38.7K -2,500 -71%
APP
108
Avantax Planning Partners
Iowa
$14K +$15.5K +1,000 New
LFAS
109
Level Four Advisory Services
Texas
$14K +$15.8K +1,018 New
Zurich Cantonal Bank
110
Zurich Cantonal Bank
Switzerland
$13K – – –
MA
111
MUFG Americas
New York
$8K +$991 +64 +13%
LTFS
112
Ladenburg Thalmann Financial Services
Florida
$7K – – –
NFG
113
Next Financial Group
Texas
$7K – – –
RFA
114
Reilly Financial Advisors
California
$7K – – –
CHP
115
Cable Hill Partners
Oregon
$3K – – –
MFS
116
MSI Financial Services
Massachusetts
$3K +$2.38K +154 +592%
IA
117
IFP Advisors
Florida
$2K -$155 -10 -7%
PMFA
118
Plante Moran Financial Advisors
Michigan
$2K – – –
PNC Financial Services Group
119
PNC Financial Services Group
Pennsylvania
$2K – – –
JP Morgan Chase
120
JP Morgan Chase
New York
$2K +$2.51K +162 New
TWA
121
TCI Wealth Advisors
Arizona
$1K -$1.86K -120 -71%
Fifth Third Bancorp
122
Fifth Third Bancorp
Ohio
$1K – – –
JWA
123
JFS Wealth Advisors
Pennsylvania
$1K – – –
SFG
124
SevenBridge Financial Group
Pennsylvania
$1K – – –
AA
125
Ancora Advisors
Ohio
$1K +$620 +40 New
2 3 4
5
6

ARNA Hedge Fund Activity: Q4 2016 in Review

128 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2016, worth a combined $160M — down 24% from $210M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ARNA positions and 14 closed out — a net gain of 4 holders — while 52 added to existing stakes and 32 trimmed.

The largest buyer was Ascend Capital, opening a new position worth an estimated $2.83M. The largest seller was Fidelity Investments, cutting an estimated $11.8M.

  • 128 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2016, up from 125 in Q3 2016.
  • Funds reported $160M of Arena Pharmaceuticals Inc stock for Q4 2016, down 24% quarter-over-quarter.
  • 18 funds opened new Arena Pharmaceuticals Inc positions in Q4 2016 and 14 closed out, a net change of +4 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2016 was Ascend Capital, an estimated $2.83M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2016 was Fidelity Investments, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2016.